Literature DB >> 15527608

The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study.

Jo C Dumville1, Amanda J Lee, Felicity B Smith, F Gerald R Fowkes.   

Abstract

BACKGROUND: Previous studies investigating the health-related quality of life of those with peripheral arterial disease have focused on patients recruited from hospital clinics. The health-related quality of life of people with peripheral arterial disease in the general population is unknown. AIMS: We aimed to determine the health-related quality of life of people with intermittent claudication and asymptomatic peripheral arterial disease in the general population and to compare it with those with angina and those with no peripheral arterial disease or angina. DESIGN OF STUDY: Analysis of cross-sectional data from the 12-year follow-up of a population-based cohort.
SETTING: Edinburgh, Scotland.
METHOD: Data from the Edinburgh Artery Study cohort's 12-year follow-up was analysed. Participants' peripheral arterial disease status was measured using the World Health Organisation intermittent claudication questionnaire and the ankle brachial pressure index. Self-assessed health-related quality of life data was collected using the SF-36 generic questionnaire. Health-related quality of life scores were calculated and their associations with peripheral arterial disease status groups were tested.
RESULTS: Subjects with intermittent claudication had significantly worse median health-related quality of life scores than patients without claudication in all domains except social functioning and mental health. Patients with claudication had a significantly lower physical component summary score than those without claudication (P </= 0.001). This association remained after adjustment for age, sex, social class, body mass index, smoking, and angina. Those with angina and claudication had significantly worse physical component summary scores than those with no peripheral arterial disease or angina (P </= 0.001). No significant difference was found in health-related quality of life scores between those with asymptomatic peripheral arterial disease and those with no peripheral arterial disease even after multiple adjustment for confounding factors.
CONCLUSION: People with intermittent claudication in the community had impaired health-related quality of life related to reduced physical health, but asymptomatic peripheral arterial disease did not significantly affect health-related quality of life.

Entities:  

Mesh:

Year:  2004        PMID: 15527608      PMCID: PMC1324915     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  23 in total

1.  Management of intermittent claudication.

Authors:  C P Shearman
Journal:  Br J Surg       Date:  2002-05       Impact factor: 6.939

Review 2.  Functional outcomes and quality of life in peripheral arterial disease: current status.

Authors:  Mark R Nehler; Mary M McDermott; Diane Treat-Jacobson; Ian Chetter; Judith G Regensteiner
Journal:  Vasc Med       Date:  2003-05       Impact factor: 3.239

3.  Quality of life in a group of patients with intermittent claudication.

Authors:  E Ponte; S Cattinelli
Journal:  Angiology       Date:  1996-03       Impact factor: 3.619

4.  The new subjective medicine: taking the patient's point of view on health care and health.

Authors:  Mark Sullivan
Journal:  Soc Sci Med       Date:  2003-04       Impact factor: 4.634

Review 5.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

6.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.

Authors:  F G Fowkes; E Housley; E H Cawood; C C Macintyre; C V Ruckley; R J Prescott
Journal:  Int J Epidemiol       Date:  1991-06       Impact factor: 7.196

7.  Quality of life in patients with intermittent claudication.

Authors:  H S Khaira; R Hanger; C P Shearman
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-01       Impact factor: 7.069

8.  Areas of concern, quality of life and life satisfaction in patients with peripheral vascular disease.

Authors:  A Hallin; D Bergqvist; K Fugl-Meyer; L Holmberg
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-09       Impact factor: 7.069

9.  Impact of intermittent claudication on quality of life. The Scottish Vascular Audit Group.

Authors:  J P Pell
Journal:  Eur J Vasc Endovasc Surg       Date:  1995-05       Impact factor: 7.069

10.  Quality of life and objective disease criteria in patients with intermittent claudication in general practice.

Authors:  Uwe Müller-Bühl; Peter Engeser; Hans-Dieter Klimm; Armin Wiesemann
Journal:  Fam Pract       Date:  2003-02       Impact factor: 2.267

View more
  33 in total

1.  Food Insecurity and Peripheral Arterial Disease in Older Adult Populations.

Authors:  M L Redmond; F Dong; J Goetz; L T Jacobson; T C Collins
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 2.  Peripheral artery disease: epidemiology and global perspectives.

Authors:  F Gerry R Fowkes; Victor Aboyans; Freya J I Fowkes; Mary M McDermott; Uchechukwu K A Sampson; Michael H Criqui
Journal:  Nat Rev Cardiol       Date:  2016-11-17       Impact factor: 32.419

3.  LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?

Authors:  Amy W Pollak; Christopher M Kramer
Journal:  Clin Lipidol       Date:  2012-04-01

Review 4.  The Safety of Paclitaxel-Coated Devices for Patients with Peripheral Artery Disease.

Authors:  Anna K Krawisz; Eric A Secemsky
Journal:  Curr Cardiol Rep       Date:  2021-03-18       Impact factor: 2.931

5.  Minimal clinically important differences in treadmill, 6-minute walk, and patient-based outcomes following supervised and home-based exercise in peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang
Journal:  Vasc Med       Date:  2018-04-19       Impact factor: 3.239

Review 6.  Antithrombotic treatment for peripheral arterial disease.

Authors:  Daniel G Hackam; John W Eikelboom
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

7.  Quality of life after peripheral bypass surgery: a 1 year follow-up.

Authors:  Hristina Vlajinac; Jelena Marinkovic; Slobodan Tanaskovic; Nikola Kocev; Djordje Radak; Dragana Davidovic; Milos Maksimovic
Journal:  Wien Klin Wochenschr       Date:  2014-11-25       Impact factor: 1.704

8.  Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study.

Authors:  M Muller; H M Jochemsen; F L J Visseren; A M Grool; L J Launer; Y van der Graaf; M I Geerlings
Journal:  J Intern Med       Date:  2013-04-11       Impact factor: 8.989

Review 9.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

10.  Leg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in patients with peripheral artery disease.

Authors:  Jacob C Monroe; Chen Lin; Susan M Perkins; Yan Han; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  J Appl Physiol (1985)       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.